Latest news with #Berenberg Bank
Globe and Mail
4 days ago
- Business
- Globe and Mail
Berenberg Bank Remains a Hold on Roche Holding AG (RHHVF)
In a report released yesterday, Kerry Holford from Berenberg Bank maintained a Hold rating on Roche Holding AG, with a price target of CHF290.00. The company's shares closed yesterday at $320.35. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Holford covers the Healthcare sector, focusing on stocks such as Novartis AG, GlaxoSmithKline, and GlaxoSmithKline. According to TipRanks, Holford has an average return of 11.9% and a 62.65% success rate on recommended stocks. In addition to Berenberg Bank, Roche Holding AG also received a Hold from Barclays's Emily Field in a report issued on July 16. However, on July 14, J.P. Morgan maintained a Sell rating on Roche Holding AG (Other OTC: RHHVF). The company has a one-year high of $354.19 and a one-year low of $269.80. Currently, Roche Holding AG has an average volume of 11.8K.
Globe and Mail
11-07-2025
- Business
- Globe and Mail
Berenberg Bank Remains a Hold on Novartis AG (NOVN)
In a report released yesterday, Kerry Holford from Berenberg Bank maintained a Hold rating on Novartis AG, with a price target of CHF89.00. The company's shares opened today at CHF97.91. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Holford is a 4-star analyst with an average return of 11.9% and a 62.65% success rate. Holford covers the Healthcare sector, focusing on stocks such as Novartis AG, GlaxoSmithKline, and GlaxoSmithKline. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Novartis AG with a CHF102.73 average price target, which is a 4.92% upside from current levels. In a report released on July 4, UBS also maintained a Hold rating on the stock with a CHF104.00 price target. The company has a one-year high of CHF102.72 and a one-year low of CHF81.10. Currently, Novartis AG has an average volume of 3.31M.
Globe and Mail
11-07-2025
- Business
- Globe and Mail
Berenberg Bank Sticks to Their Hold Rating for Novartis (NVS)
In a report released yesterday, Kerry Holford from Berenberg Bank maintained a Hold rating on Novartis, with a price target of $108.00. The company's shares closed yesterday at $122.94. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Holford is a 4-star analyst with an average return of 12.0% and a 62.65% success rate. Holford covers the Healthcare sector, focusing on stocks such as Novartis AG, GlaxoSmithKline, and Novartis. Currently, the analyst consensus on Novartis is a Moderate Buy with an average price target of $117.84. NVS market cap is currently $234.6B and has a P/E ratio of 18.92.
